Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up. J. Pharm. Nutr. Sci. 2022, 12, 74-79. https://doi.org/10.29169/1927-5951.2022.12.06.